Every stored oracle finding for this trial, including pending, dismissed, rejected, superseded, and accepted items.
NO_DECISIONDismissed100% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial NCT04895696 remains active not recruiting per sponsor and registry sites as of 2025-2026 crawls. No public topline results, readouts, or SRI(4) data found despite targeted searches. Primary completion estimated Mar 2026; no evidence of completed readout.
Found Apr 6, 2026, 2:59 PMReviewed Apr 6, 2026, 3:00 PM
NO_DECISIONDismissed90% confidenceGrok 4.20 (xAI)
Will the results be positive?
Trial is active, not recruiting with primary completion in Mar 2026. No public efficacy readout or topline results for this exact Phase 2 SLE SRI-4 trial found. Prior CLE Phase 1b data positive but not applicable here.
Found Apr 6, 2026, 2:10 PMReviewed Apr 6, 2026, 2:19 PM
Web Searchbmsstudyconnect.comJun 9, 2025, 12:00 AM
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
Active, not recruiting. Phase 2 trial of afimetoran vs placebo in active SLE. Primary: SRI(4) at Week 48. Estimated primary completion 2026-03-29.
Web Searchacrjournals.onlinelibrary.wiley.comJun 26, 2025, 12:00 AM
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran... in Patients With Cutaneous Lupus Erythematosus
Positive Phase 1b CLE data supports continued investigation of afimetoran in lupus, including the ongoing Phase 2b study in SLE (NCT04895696).
NO_DECISIONDismissed90% confidencemanual-chat-review
Will the results be positive?
ClinicalTrials.gov still lists this study as active not recruiting with no posted results, so there is not yet a clear public positive or negative trial readout.
Found Apr 4, 2026, 8:54 PMReviewed Apr 4, 2026, 10:33 PM
NO_DECISIONDismissed95% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found. Authoritative sources still describe NCT04895696 as an ongoing/active Phase 2 SLE study, so there is not enough public evidence to label this exact trial positive or negative.
Found Apr 3, 2026, 4:30 PMReviewed Apr 3, 2026, 4:47 PM
NO_DECISIONDismissed95% confidenceGPT-5.4 (OpenAI)
Will the results be positive?
No trial-specific public efficacy readout was found. The sponsor page still says the Phase 2 study is ongoing and not recruiting, and a trial-tracking source lists results status as ongoing with no actual reporting date. Without a clear public readout for NCT04895696, outcome cannot be classified positive or negative.
Found Apr 1, 2026, 7:54 PMReviewed Apr 1, 2026, 7:55 PM